logo
#

Latest news with #EduardoLópezBran

New Stem Cell Therapy Shows 'Promising' Results For Treating Hair Loss In Preclinical Trials
New Stem Cell Therapy Shows 'Promising' Results For Treating Hair Loss In Preclinical Trials

Gulf Insider

time6 days ago

  • Health
  • Gulf Insider

New Stem Cell Therapy Shows 'Promising' Results For Treating Hair Loss In Preclinical Trials

Researchers at the San Carlos Clinical Hospital in Madrid may have targeted a potential solution for hair loss. A recent study analyzed the effect of injecting mice's skin with stem cells from human fat — 'adipose-derived stem cells (ASCs)' — as a means of treating androgenetic alopecia (AGA), more commonly known as male- or female-pattern hair loss. The team found that male mice achieved the best hair regrowth after three weeks when they received low-dose ASCs, combined with an energy-boosting molecule called adenosine triphosphate (ATP). Low-dose and high-dose ASC treatments along with ATP led to no hair regrowth improvement in females, but medium-dose ASC plus ATP led to greater regrowth. The researchers concluded that hair regrowth was improved in 'all experimental groups' where male mice received stem cell solutions supplemented with ATP. Researchers at the San Carlos Clinical Hospital in Madrid may have targeted a potential solution for hair loss. (iStock) The findings were published in the journal Stem Cell Research & Therapy. Lead study author Dr. Eduardo López Bran — dermatologist and professor at The Complutense University of Madrid — shared his expectations for the study in an interview with Fox News Digital. 'We expected good results, but not such a high level of success,' he said. 'We're talking about a very high degree of hair regrowth in both male and female mice.' With appropriate doses, the researchers achieved 'very high percentages' of hair regrowth, noting that 100% of the male mice and up to 90% of the female mice regrew hair. With appropriate doses, the researchers achieved 'very high percentages' of hair regrowth, noting that 100% of the male mice and up to 90% of the female mice regrew hair. (Actual mice from the study not pictured.) (iStock) 'These results demonstrate that advanced therapies may represent a new therapeutic approach for many diseases for which no effective treatments are currently available,' Bran went on. 'Achieving such promising results in the preclinical phase with a completely novel approach to androgenetic alopecia — one that avoids chronic treatment and is also safe — is a significant scientific milestone.' 'We're talking about a very high degree of hair regrowth in both male and female mice.' The main limitation of the study was the thinness of mouse skin, Bran noted, which 'posed a challenge in administering the therapy.' 'This required the development of protocols to minimize experimental variability, and will be a key factor when studies in humans begin,' he said. 'Research advances are pointing toward possible solutions that, in the future, may offer long-lasting results without the need for continuous treatment to maintain benefits.' (iStock) These new findings should be 'interpreted with caution and scientific rigor,' Bran cautioned. 'Although the results in mice represent significant progress, it is also true that it is essential to wait for clinical benefits in humans to be confirmed.' The researcher encouraged those with androgenetic alopecia to continue consulting with their dermatologists and to follow prescribed treatments as research develops. 'It is important to remain hopeful. Research advances are pointing toward possible solutions that, in the future, may offer long-lasting results without the need for continuous treatment to maintain benefits,' Bran added. 'This study is small, and more research is needed on this method as a potential treatment option.' Looking ahead to human clinical trials, researchers are 'actively working' on confirming safety for men and women between 18 and 50 years old with moderate androgenetic alopecia, the researcher noted. 'If everything progresses as expected, the most optimistic timeline points to the treatment becoming available in approximately five years,' he said. Looking ahead to human clinical trials, researchers are 'actively working' on confirming safety for men and women between 18 and 50 years old with moderate androgenetic alopecia. (iStock) In a separate interview with Fox News Digital, Dr. Brendan Camp, M.D., a New York-based dermatologist who was not involved in the study, commented on the potential for this method. 'While not commercially available, this study suggests that injection of stem cells supplemented with ATP into scalp skin could potentially encourage hair regrowth in individuals with androgenetic alopecia,' he reiterated.

New stem cell therapy shows 'promising' results for treating hair loss in preclinical trials
New stem cell therapy shows 'promising' results for treating hair loss in preclinical trials

Yahoo

time25-06-2025

  • Health
  • Yahoo

New stem cell therapy shows 'promising' results for treating hair loss in preclinical trials

Researchers at the San Carlos Clinical Hospital in Madrid may have targeted a potential solution for hair loss. A recent study analyzed the effect of injecting mice's skin with stem cells from human fat — "adipose-derived stem cells (ASCs)" — as a means of treating androgenetic alopecia (AGA), more commonly known as male- or female-pattern hair loss. The team found that male mice achieved the best hair regrowth after three weeks when they received low-dose ASCs, combined with an energy-boosting molecule called adenosine triphosphate (ATP). Hairstylists And Medical Expert Confirm Temporary Hair Loss Affecting Ozempic Users Low-dose and high-dose ASC treatments along with ATP led to no hair regrowth improvement in females, but medium-dose ASC plus ATP led to greater regrowth. The researchers concluded that hair regrowth was improved in "all experimental groups" where male mice received stem cell solutions supplemented with ATP. Read On The Fox News App The findings were published in the journal Stem Cell Research & Therapy. Lead study author Dr. Eduardo López Bran — dermatologist and professor at The Complutense University of Madrid — shared his expectations for the study in an interview with Fox News Digital. This Daily Beauty Routine Could Be Ruining Your Hair, Experts Warn "We expected good results, but not such a high level of success," he said. "We're talking about a very high degree of hair regrowth in both male and female mice." With appropriate doses, the researchers achieved "very high percentages" of hair regrowth, noting that 100% of the male mice and up to 90% of the female mice regrew hair. "These results demonstrate that advanced therapies may represent a new therapeutic approach for many diseases for which no effective treatments are currently available," Bran went on. "Achieving such promising results in the preclinical phase with a completely novel approach to androgenetic alopecia — one that avoids chronic treatment and is also safe — is a significant scientific milestone." The main limitation of the study was the thinness of mouse skin, Bran noted, which "posed a challenge in administering the therapy." "This required the development of protocols to minimize experimental variability, and will be a key factor when studies in humans begin," he said. These new findings should be "interpreted with caution and scientific rigor," Bran cautioned. "Although the results in mice represent significant progress, it is also true that it is essential to wait for clinical benefits in humans to be confirmed." Click Here To Sign Up For Our Health Newsletter The researcher encouraged those with androgenetic alopecia to continue consulting with their dermatologists and to follow prescribed treatments as research develops. "It is important to remain hopeful. Research advances are pointing toward possible solutions that, in the future, may offer long-lasting results without the need for continuous treatment to maintain benefits," Bran added. Looking ahead to human clinical trials, researchers are "actively working" on confirming safety for men and women between 18 and 50 years old with moderate androgenetic alopecia, the researcher noted. "If everything progresses as expected, the most optimistic timeline points to the treatment becoming available in approximately five years," he said. In a separate interview with Fox News Digital, Dr. Brendan Camp, M.D., a New York-based dermatologist who was not involved in the study, commented on the potential for this method. "While not commercially available, this study suggests that injection of stem cells supplemented with ATP into scalp skin could potentially encourage hair regrowth in individuals with androgenetic alopecia," he reiterated. For more Health articles, visit "This study is small, and more research is needed on this method as a potential treatment option for androgenetic alopecia." Until then, Camp encourages people to focus on currently available and "well-studied" treatments to address hair loss, and to visit a board-certified dermatologist for article source: New stem cell therapy shows 'promising' results for treating hair loss in preclinical trials

New stem cell therapy shows 'promising' results for treating hair loss in preclinical trials
New stem cell therapy shows 'promising' results for treating hair loss in preclinical trials

Fox News

time25-06-2025

  • Health
  • Fox News

New stem cell therapy shows 'promising' results for treating hair loss in preclinical trials

Print Close By Angelica Stabile Published June 25, 2025 Researchers at the San Carlos Clinical Hospital in Madrid may have targeted a potential solution for hair loss. A recent study analyzed the effect of injecting mice's skin with stem cells from human fat — "adipose-derived stem cells (ASCs)" — as a means of treating androgenetic alopecia (AGA), more commonly known as male- or female-pattern hair loss. The team found that male mice achieved the best hair regrowth after three weeks when they received low-dose ASCs, combined with an energy-boosting molecule called adenosine triphosphate (ATP). HAIRSTYLISTS AND MEDICAL EXPERT CONFIRM TEMPORARY HAIR LOSS AFFECTING OZEMPIC USERS Low-dose and high-dose ASC treatments along with ATP led to no hair regrowth improvement in females, but medium-dose ASC plus ATP led to greater regrowth. The researchers concluded that hair regrowth was improved in "all experimental groups" where male mice received stem cell solutions supplemented with ATP. The findings were published in the journal Stem Cell Research & Therapy. Lead study author Dr. Eduardo López Bran — dermatologist and professor at The Complutense University of Madrid — shared his expectations for the study in an interview with Fox News Digital. THIS DAILY BEAUTY ROUTINE COULD BE RUINING YOUR HAIR, EXPERTS WARN "We expected good results, but not such a high level of success," he said. "We're talking about a very high degree of hair regrowth in both male and female mice." With appropriate doses, the researchers achieved "very high percentages" of hair regrowth, noting that 100% of the male mice and up to 90% of the female mice regrew hair. "These results demonstrate that advanced therapies may represent a new therapeutic approach for many diseases for which no effective treatments are currently available," Bran went on. "Achieving such promising results in the preclinical phase with a completely novel approach to androgenetic alopecia — one that avoids chronic treatment and is also safe — is a significant scientific milestone." "We're talking about a very high degree of hair regrowth in both male and female mice." The main limitation of the study was the thinness of mouse skin, Bran noted, which "posed a challenge in administering the therapy." CLICK HERE TO GET THE FOX NEWS APP "This required the development of protocols to minimize experimental variability, and will be a key factor when studies in humans begin," he said. These new findings should be "interpreted with caution and scientific rigor," Bran cautioned. "Although the results in mice represent significant progress, it is also true that it is essential to wait for clinical benefits in humans to be confirmed." CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER The researcher encouraged those with androgenetic alopecia to continue consulting with their dermatologists and to follow prescribed treatments as research develops. "It is important to remain hopeful. Research advances are pointing toward possible solutions that, in the future, may offer long-lasting results without the need for continuous treatment to maintain benefits," Bran added. "This study is small, and more research is needed on this method as a potential treatment option." Looking ahead to human clinical trials, researchers are "actively working" on confirming safety for men and women between 18 and 50 years old with moderate androgenetic alopecia, the researcher noted. "If everything progresses as expected, the most optimistic timeline points to the treatment becoming available in approximately five years," he said. In a separate interview with Fox News Digital, Dr. Brendan Camp, M.D., a New York-based dermatologist who was not involved in the study, commented on the potential for this method. "While not commercially available, this study suggests that injection of stem cells supplemented with ATP into scalp skin could potentially encourage hair regrowth in individuals with androgenetic alopecia," he reiterated. For more Health articles, visit "This study is small, and more research is needed on this method as a potential treatment option for androgenetic alopecia." Until then, Camp encourages people to focus on currently available and "well-studied" treatments to address hair loss, and to visit a board-certified dermatologist for evaluation. Print Close URL

Breakthrough cure for baldness: 100% of male mice regrew fur with new treatment
Breakthrough cure for baldness: 100% of male mice regrew fur with new treatment

New York Post

time19-06-2025

  • Health
  • New York Post

Breakthrough cure for baldness: 100% of male mice regrew fur with new treatment

It's the bald truth. Researchers at San Carlos Clinical Hospital in Madrid have developed a cure for androgenetic alopecia, commonly known as pattern hair loss. An estimated 80 million Americans — 50 million men and 30 million women — experience some form of alopecia, although it affects women differently than men. Advertisement Researchers at San Carlos Clinical Hospital in Madrid have developed a cure for androgenetic alopecia — commonly known as pattern hair loss. Phimchanok – Men usually go through a receding hairline and bald spots, whereas women get thinner at the part line but rarely go fully bald. In the study — published in the journal Stem Cell Research and Therapy — researchers used a combo of fat‑tissue-derived stem cells and the energy molecule ATP to reverse hair loss in mice, with shocking results. Advertisement All of the male mice grew back their coats. Half had full regrowth, while the other half had intensive regrowth. Among females, a whopping 90% saw intense or complete hair revival. Eduardo López Bran, head of the Dermatology Department at the Hospital Clínico San Carlos, explained that their special method 'stimulates hair regeneration by combining the regenerative capacity of the former with the energy provided by the latter. This synergy favors the recovery of the hair follicle, promoting hair growth.' While the findings will need to be replicated in human trials, the results pave a promising way forward in the fight against hair loss. Advertisement All of the male mice grew back their coats. Among females, a whopping 90% saw intense or complete hair revival. Javier – 'In the future, we will be able to offer new solutions that allow us to meet patients' expectations, allowing them access to new treatments that prioritize their well-being,' Eduardo López Bran said. It's an exciting development in an area where there's plenty of room for growth. Advertisement While hair transplant surgery is on the rise, many people don't realize that it actually often takes several procedures to achieve the desired result. 'An alarming trend is patients who now go to perform a hair transplant by a physician who does not consult the patient about his or her hair loss nor is he actively involved in the surgery,' Texas facial plastic surgeon and hair restoration expert Dr. Samuel Lam previously told The Post. He noted that this troubling practice is 'most rampant' in Turkey — where hair transplant surgery has exploded due to its relative affordability — but it is 'also extremely prevalent in the US, unfortunately.' Meanwhile, some men have been vocal about how post-finasteride syndrome (PFS) — a condition in which someone experiences severe side effects after they stop using finasteride — has completely upended their lives. One woman even recently chronicled how PFS destroyed her husband's sex drive — and ended their marriage. Researchers are racing to find new, safer and more affordable hair loss treatments, inventing non-hormonal pills and gummies and repurposing older drugs to find a sustainable solution.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store